Review



imr90 human lung fibroblasts  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    ATCC imr90 human lung fibroblasts
    Imr90 Human Lung Fibroblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 2160 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+imr90+lung+fibroblasts/pm42209493-241-0-4?v=ATCC
    Average 99 stars, based on 2160 article reviews
    imr90 human lung fibroblasts - by Bioz Stars, 2026-08
    99/100 stars

    Images



    Similar Products

    imr90 human lung fibroblasts  (ATCC)
    99
    ATCC imr90 human lung fibroblasts
    Imr90 Human Lung Fibroblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+imr90+lung+fibroblasts/pm42209493-241-0-4?v=ATCC
    Average 99 stars, based on 1 article reviews
    imr90 human lung fibroblasts - by Bioz Stars, 2026-08
    99/100 stars
    		  Buy from Supplier
    human imr90 lung fibroblasts human imr90 lung fibroblasts  (ATCC)
    99
    ATCC human imr90 lung fibroblasts human imr90 lung fibroblasts
    Human Imr90 Lung Fibroblasts Human Imr90 Lung Fibroblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+imr90+lung+fibroblasts/pm41922652-185-0-11?v=ATCC
    Average 99 stars, based on 1 article reviews
    human imr90 lung fibroblasts human imr90 lung fibroblasts - by Bioz Stars, 2026-08
    99/100 stars
    		  Buy from Supplier
    imr90 human lung fibroblast  (ATCC)
    99
    ATCC imr90 human lung fibroblast
    Imr90 Human Lung Fibroblast, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+imr90+lung+fibroblasts/pmc12834841-343-6-10?v=ATCC
    Average 99 stars, based on 1 article reviews
    imr90 human lung fibroblast - by Bioz Stars, 2026-08
    99/100 stars
    		  Buy from Supplier
    human imr90 lung fibroblasts  (ATCC)
    96
    ATCC human imr90 lung fibroblasts
    Human Imr90 Lung Fibroblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+imr90+lung+fibroblasts/10__1016_slash_j__cpblue__2026__100004-334-0-7?v=ATCC
    Average 96 stars, based on 1 article reviews
    human imr90 lung fibroblasts - by Bioz Stars, 2026-08
    96/100 stars
    		  Buy from Supplier
    non cancer cell line imr90 human lung fibroblast  (ATCC)
    99
    ATCC non cancer cell line imr90 human lung fibroblast
    Non Cancer Cell Line Imr90 Human Lung Fibroblast, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+imr90+lung+fibroblasts/pmc12838262-346-25-32?v=ATCC
    Average 99 stars, based on 1 article reviews
    non cancer cell line imr90 human lung fibroblast - by Bioz Stars, 2026-08
    99/100 stars
    		  Buy from Supplier
    human lung fibroblasts imr90  (ATCC)
    99
    ATCC human lung fibroblasts imr90
    (A) Viability of human <t>IMR90</t> cells after treatment with different doses of ENU. Proliferating cells were treated with ENU doses ranging from 25–500 μg/ml and the number of viable cells was assessed 72 hrs after treatment as a percentage of the control population (1-way ANOVA, R 2 = 0.9747); (B) Percentage of cells in early (Annexin positive) and late stage (7-AAD) apoptosis; (C) Viability of ENU-treated cells when confluent; (D) SNV frequency in human IMR90 cells after treatment with 20 or 100 μg/ml (1-way ANOVA, R 2 = 0.9259). IMR90: Institute for Medical Research-90; ENU: N-ethyl-N-nitrosourea; ANOVA: analysis of variance; 7-AAD: 7-aminoactinomycin D; SNV: single nucleotide variant.
    Human Lung Fibroblasts Imr90, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+imr90+lung+fibroblasts/pmc13233046-40-2-9?v=ATCC
    Average 99 stars, based on 1 article reviews
    human lung fibroblasts imr90 - by Bioz Stars, 2026-08
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) Viability of human IMR90 cells after treatment with different doses of ENU. Proliferating cells were treated with ENU doses ranging from 25–500 μg/ml and the number of viable cells was assessed 72 hrs after treatment as a percentage of the control population (1-way ANOVA, R 2 = 0.9747); (B) Percentage of cells in early (Annexin positive) and late stage (7-AAD) apoptosis; (C) Viability of ENU-treated cells when confluent; (D) SNV frequency in human IMR90 cells after treatment with 20 or 100 μg/ml (1-way ANOVA, R 2 = 0.9259). IMR90: Institute for Medical Research-90; ENU: N-ethyl-N-nitrosourea; ANOVA: analysis of variance; 7-AAD: 7-aminoactinomycin D; SNV: single nucleotide variant.

    Journal: Geromedicine

    Article Title: Mutagen-induced somatic mutation rate in primary mammalian cells in relation to maximum life span

    doi: 10.70401/geromedicine.2026.0023

    Figure Lengend Snippet: (A) Viability of human IMR90 cells after treatment with different doses of ENU. Proliferating cells were treated with ENU doses ranging from 25–500 μg/ml and the number of viable cells was assessed 72 hrs after treatment as a percentage of the control population (1-way ANOVA, R 2 = 0.9747); (B) Percentage of cells in early (Annexin positive) and late stage (7-AAD) apoptosis; (C) Viability of ENU-treated cells when confluent; (D) SNV frequency in human IMR90 cells after treatment with 20 or 100 μg/ml (1-way ANOVA, R 2 = 0.9259). IMR90: Institute for Medical Research-90; ENU: N-ethyl-N-nitrosourea; ANOVA: analysis of variance; 7-AAD: 7-aminoactinomycin D; SNV: single nucleotide variant.

    Article Snippet: Commercially available human lung fibroblasts (IMR90) were obtained via ATCC (CCL-186).

    Techniques: Control, Variant Assay